Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Expands Services to Healthcare Industry with Addition of Top Department of Justice Attorney John Kelly

January 13, 2012

New Washington, D.C. Office to Provide Clients with Compliance and Government Investigations Support

Nashville, Tenn. (January 13, 2012) - Bass, Berry & Sims PLC is pleased to announce the addition of John Kelly, a former top U.S. Department of Justice official, as a partner in the firm's Compliance and Government Investigations Practice. Kelly will be the managing partner in the firm's Washington, D.C. office. He has extensive experience with complex federal and state investigations and litigation matters related to healthcare fraud and abuse, the False Claims Act, white collar crime, the Foreign Corrupt Practices Act, and regulatory and compliance issues.

Kelly most recently was a partner at Fulbright & Jaworski, L.L.P., following a distinguished record of service with the Department of Justice where he held a number of prestigious leadership positions including serving in the Criminal Division's Fraud Section as the Assistant Chief for Health Care Fraud. He also served as the Chief of Staff and Deputy Director of the Executive Office for U.S. Attorneys, where he worked closely with senior leadership within the 94 U.S. Attorneys' Offices, the Department of Justice, and various federal agencies including HHS-OIG, FBI, and DEA. Prior to joining DOJ, Kelly gained extensive trial and investigation experience as an Assistant United States Attorney in New York State.

"John Kelly's arrival, and the growth of our new Washington, D.C. office, is of immense value to our current and future clients in Nashville – the nation's top for-profit healthcare market – as well as our healthcare clients nationally in this historic time of change," said Keith Simmons, managing partner of Bass, Berry & Sims PLC.

"John brings an insider's knowledge of the Beltway that will have a direct and beneficial impact on our clients who are so directly affected by legislative and regulatory decisions made at the federal level," added Simmons.

"It is an honor to now be a part of this prestigious law firm," said Kelly. "Bass, Berry & Sims has a stellar client list and I welcome the opportunity to represent their interests in the nation's capital."

Bass, Berry & Sims has distinguished itself for service to healthcare clients at every level, including service to hospitals, pharmaceutical companies, home health, and physician practice management companies. The healthcare practice, including more than 100 lawyers, provides unsurpassed depth in government investigations and enforcement, compliance, regulatory and operational matters, mergers and acquisitions, and joint ventures and syndications.

About Bass, Berry & Sims PLC
With more than 200 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant business transactions and litigation matters in the country. For more information, please visit

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.